Journal
JOURNAL OF OPHTHALMIC & VISION RESEARCH
Volume 17, Issue 2, Pages 276-289Publisher
KNOWLEDGE E
DOI: 10.18502/jovr.v17i2.10804
Keywords
Corticosteroids; Immunosuppression; Uveitis
Categories
Ask authors/readers for more resources
Uveitis is a common cause of vision loss and blindness worldwide. To ensure personalized treatment, it is important to understand the safety and efficacy of medications used for ocular inflammation. This article reviewed the effectiveness of systemic biologic response modifiers and local treatments commonly used in the management of noninfectious uveitis.
Uveitis is one of the most common causes of vision loss and blindness worldwide. Local and/or systemic immunosuppression is often required to treat ocular inflammation in noninfectious uveitis. An understanding of safety and efficacy of these medications is required to individualize treatment to each patient to ensure compliance and achieve the best outcome. In this article, we reviewed the effectiveness of systemic biologic response modifiers and local treatments commonly used in the management of patients with noninfectious uveitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available